Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from CSL ( (AU:CSL) ).
CSL Limited announced its Capital Markets Day event to be held in Chicago, Illinois, USA. The event will provide insights into the company’s strategic direction and operational performance, with recordings available online for those unable to attend due to time zone differences. This event reflects CSL’s commitment to transparency and engagement with its investors, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$248.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited is a global biotechnology company that specializes in the development and manufacturing of innovative medicines. The company is focused on delivering life-saving therapies and services in the areas of immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Average Trading Volume: 1,349,471
Technical Sentiment Signal: Sell
Current Market Cap: A$85.87B
Find detailed analytics on CSL stock on TipRanks’ Stock Analysis page.